Karim Alavi1, Sook Chan2, Paul Wise3, Andreas M Kaiser4, Ranjan Sudan5, Liliana Bordeianou6. 1. Division of Colon and Rectal Surgery, University of Massachusetts Memorial Medical Center, 67 Belmont Street, Worcester, MA, 01605, USA. karim.alavi@umassmemorial.org. 2. Division of Colon and Rectal Surgery, University of Massachusetts Memorial Medical Center, 67 Belmont Street, Worcester, MA, 01605, USA. 3. Division of Colon and Rectal Surgery, Washington University School of Medicine, St Louis, MO, USA. 4. Division of Colon and Rectal Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. 5. Department of Surgery, Duke University School of Medicine, Durham, NC, USA. 6. Division of Colon and Rectal Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
INTRODUCTION: Fecal incontinence is a debilitating condition affecting primarily the elderly. Many patients suffer in silence resulting in both underdiagnosis and undertreatment often culminating in an overall poor quality of life. METHODS: We sought to review the etiology, diagnosis, and treatment of fecal incontinence based on current literature. Additionally, newer treatment methods such as Solesta will be evaluated. RESULTS: There are many diagnostic modalities available to assess the degree and severity of the patient's incontinence; however, a thorough history and physical exam is critical. Initial attempts at treatment focus on medical management primarily through stool texture modification with the aid of bulking agents. Failure of medical therapy is often followed by a graded increase in the complexity and invasiveness of the available treatment options. The selection of the most appropriate surgical option, such as overlapping sphincteroplasty and neuromodulation, is multifactorial involving both surgeon and patient-related factors. Neuromodulation has received increased attention in the last decade due to its documented therapeutic success, and newer office-based procedures, such as the Solesta injection, are showing promising results in properly selected patients. Finally, diversion remains an option for select patients who have failed all other therapies. CONCLUSION: The etiology of fecal incontinence is multifactorial, involving a complex interplay between stool consistency and anatomic integrity. The diagnosis and treatment of fecal incontinence continue to evolve and are showing promising results.
INTRODUCTION: Fecal incontinence is a debilitating condition affecting primarily the elderly. Many patients suffer in silence resulting in both underdiagnosis and undertreatment often culminating in an overall poor quality of life. METHODS: We sought to review the etiology, diagnosis, and treatment of fecal incontinence based on current literature. Additionally, newer treatment methods such as Solesta will be evaluated. RESULTS: There are many diagnostic modalities available to assess the degree and severity of the patient's incontinence; however, a thorough history and physical exam is critical. Initial attempts at treatment focus on medical management primarily through stool texture modification with the aid of bulking agents. Failure of medical therapy is often followed by a graded increase in the complexity and invasiveness of the available treatment options. The selection of the most appropriate surgical option, such as overlapping sphincteroplasty and neuromodulation, is multifactorial involving both surgeon and patient-related factors. Neuromodulation has received increased attention in the last decade due to its documented therapeutic success, and newer office-based procedures, such as the Solesta injection, are showing promising results in properly selected patients. Finally, diversion remains an option for select patients who have failed all other therapies. CONCLUSION: The etiology of fecal incontinence is multifactorial, involving a complex interplay between stool consistency and anatomic integrity. The diagnosis and treatment of fecal incontinence continue to evolve and are showing promising results.
Authors: T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry Journal: Dis Colon Rectum Date: 2000-01 Impact factor: 4.585
Authors: B J Mander; S D Wexner; N S Williams; D C Bartolo; D Z Lubowski; T Oresland; G Romano; M R Keighley Journal: Br J Surg Date: 1999-12 Impact factor: 6.939
Authors: Brian A VanderBrink; Mark P Cain; Martin Kaefer; Kirstan K Meldrum; Rosalia Misseri; Richard C Rink Journal: J Pediatr Surg Date: 2013-10 Impact factor: 2.545
Authors: Elizabeth B Yerkes; Mark P Cain; Shelly King; Timothy Brei; Martin Kaefer; Anthony J Casale; Richard C Rink Journal: J Urol Date: 2003-01 Impact factor: 7.450
Authors: Andreas M Kaiser; Guy R Orangio; Massarat Zutshi; Suraj Alva; Tracy L Hull; Peter W Marcello; David A Margolin; Janice F Rafferty; W Donald Buie; Steven D Wexner Journal: Surg Endosc Date: 2014-03-08 Impact factor: 4.584
Authors: Amr S El Haraki; S Lankford; Wencheng Li; Koudy J Williams; Catherine A Matthews; Gopal H Badlani Journal: Int Urogynecol J Date: 2022-04-21 Impact factor: 1.932
Authors: Tanya P Hoke; Isuzu Meyer; Christina T Blanchard; Jeff M Szychowski; Holly E Richter Journal: Neurourol Urodyn Date: 2020-10-20 Impact factor: 2.696